Clinical Trials Sponsored by EGEN, Inc.
Total 3 results
NCT01300858TerminatedA Study of the Safety and Biological Activity of Intraperitoneal (IP) EGEN-001 Administered Alone and in Combination With Standard Chemotherapy in Colorectal Peritoneal Carcinomatosis PatientsConditions: Colorectal Cancer
NCT00473954CompletedSafety and Efficacy of EGEN-001 Combined With Carboplatin and Docetaxel in Recurrent, Platinum-Sensitive, Ovarian CancerConditions: Ovarian Neoplasms
NCT00137865TerminatedConditions: Ovarian Neoplasms